Press release
Deadline on Dec. 28th coming up in Lawsuit filed for Investors in Celsion Corporation (NASDAQ: CLSN)
A Deadline is coming up on December 28, 2020 in the lawsuit for certain investors in Celsion Corporation (NASDAQ: CLSN).
Investors who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and there are strict and short deadlines running. Deadline: December 28, 2020. NASDAQ: CLSN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Celsion Corporation (NASDAQ: CLSN) common shares between November 2, 2015 and July 10, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 2, 2015 and July 10, 2020, the Defendants made false and/or misleading statements and/or failed to disclose that Defendants had significantly overstated the efficacy of ThermoDox, that the foregoing significantly diminished the approval and commercialization prospects for ThermoDox, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Dec. 28th coming up in Lawsuit filed for Investors in Celsion Corporation (NASDAQ: CLSN) here
News-ID: 2210491 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Celsion
Non-Viral Transfection Reagents Market Revolutionizing Gene Editing and Therapy …
According to a new report published by CoherentMI The non-viral transfection reagents market is estimated to be valued at USD 687 Mn in 2024 and is expected to reach USD 1,200 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031.
The Global Non Viral Transfection Reagents Market has recently been analyzed and explored by CoherentMI in their latest market research report. The team…
Liposome Drug Delivery Market Is Flourishing Worldwide with Major Leading Firms …
The Liposome Drug Delivery Market is expected to reach US$ 6,992.95 million by 2030 from US$ 3,594.41 million in 2022. The market is estimated to grow at a CAGR of +8% from 2023 to 2030.
Liposomes, a novel drug delivery system (NDDS), are bilayer vesicular structures used in delivering drugs or genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the…
North America Liposome Drug Delivery Market Analysis and Experts Review Report 2 …
The report presents an in-depth assessment of the 'North America Liposome Drug Delivery Market'. This includes enabling demand, key trends, market drivers, challenges, competition, standardization, regulatory landscape, deployment models, competitive analysis, operator case studies, opportunities, future trends, value chains, ecosystem player profiles, and strategies included. The report also presents a SWOT analysis and forecast for North America Liposome Drug Delivery investments from 2019 to 2027.
"The North America Liposome Drug Delivery…
Liposome Drug Delivery Market to Hit US$ 6,992.95 million , Globally, by 2027 at …
According to the new market research study of "Liposome Drug Delivery Market Forecast to 2027 - the market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow with a CAGR of 8.8% from 2020 to 2027.
The liposome drug delivery market majorly consists of players such as Takeda Pharmaceutical Company Limited, Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion,…
Celsion Corporation (NASDAQ: CLSN) Long Term Investor Notice: Investigation of p …
An investigation was announced over possible breaches of fiduciary duties by certain directors and officers of Celsion Corporation.
Investors who are current long term investors in Celsion Corporation (NASDAQ: CLSN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: CLSN stocks follows a lawsuit filed against Celsion Corporation over alleged securities laws…
Lawsuit filed for Investors in shares of Celsion Corporation (NASDAQ: CLSN)
An investor, who purchased shares of Celsion Corporation (NASDAQ: CLSN), filed a lawsuit over alleged violations of Federal Securities Laws by Celsion Corporation.
Investors who purchased shares of Celsion Corporation (NASDAQ: CLSN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2020. NASDAQ: CLSN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Lawrenceville, NJ based Celsion Corporation, an integrated…
